Results

Total Results: 1,613 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
    January 01, 2014 - services include providing education and counseling, improving medication adherence, and detecting adverse … drug events and medication misuse.2 MTM services are designed to be distinct from medication-dispensing … Populations Medication misuse and poor medication adherence commonly contribute to adverse events … drug events, missed days of work/school, patient satisfaction with care, health-related quality of … events, and better or more efficient coordination of care.
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
    August 10, 2010 - children < 6 years of age with ADHD or Disruptive Behavior Disorder, what are the effectiveness and adverse … Among people 6 years of age or older with ADHD, what are the effectiveness and adverse event outcomes … • Descriptive Statistics Outcomes  Numerical or statistical results of any effectiveness or adverse … event outcomes  Numerical or statistical results of any effectiveness or adverse event outcomes … events:  physical changes: stomachaches, tics, weight loss, slowed growth, cardiac events
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-table-e1.xlsx
    March 13, 2023 - Adverse Events Table E-4. … Cannabis RCTs adverse events Author, Year Companion Paper Risk of Bias Pain Population Category Specific … In addition, the number of reported adverse events in the nabilone/ GBP group decreased by 27% from Visits … events in the study. … Cannabis RCTs adverse events
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - Adverse Events Table F-4. … Cannabis RCTs adverse events Author, Year Companion Paper Risk of Bias Pain Population Category Specific … In addition, the number of reported adverse events in the nabilone/ GBP group decreased by 27% from Visits … events in the study. … Cannabis RCTs adverse events
  5. effectivehealthcare.ahrq.gov/products/acs-pci-adjunctive-devices/research-protocol
    July 01, 2010 - larger infarcts, more significant left ventricular systolic dysfunction, and an increased risk of major adverse … cardiovascular events (MACE) or death. … events (e.g., coronary dissection, perforation, prolonged procedure time) differ between device types … events, had an adequate sample size, and used intention-to-treat analysis. 11 Studies meeting fewer … between patients in the study and the community Eligibility criteria, demographics Population Events
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
    January 01, 2011 - Effect Methods Group57 and other experts.58,59 Adverse Effects/Harms A search for adverse effects … DISEASES/ci Drug terms AND Exp LIVER DISEASE/si subheadings linked to drug name Exp DRUG NAMEadverse events … , po, to Exp DRUG NAMEadverse events, to floating subheadings Drug terms AND (ae OR po OR to OR … (effect or effects or reaction or reactions or event or events or outcome or outcomse)]) Drug terms … adj2 (effect or effects or reaction or reactions or event or events or outcome or outcomse)]) indexing
  7. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
    February 01, 2008 - brachytherapy (103Pd) implant found no significant differences in the number of biochemical failure eventsAdverse effects were reported, but definitions and severity varied widely. … • Distant metastases: No significant difference in distant failure events between groups at the median … Biochemical/clinical progression or recurrence: No difference in 6.5 weeks) compared with PSA relapse events … significant of different regimens differences between 20 Gy and 44 Gy in the number of biochemical failure events
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - Adverse Events Table F-4. … Cannabis RCTs adverse events Author, Year Companion Paper Risk of Bias Pain Population Category Specific … In addition, the number of reported adverse events in the nabilone/ GBP group decreased by 27% from Visits … events in the study. … Cannabis RCTs adverse events
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - Adverse Events Table E-4. … Cannabis RCTs adverse events Author, Year Companion Paper Risk of Bias Pain Population Category Specific … In addition, the number of reported adverse events in the nabilone/ GBP group decreased by 27% from Visits … events in the study. … Cannabis RCTs adverse events
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - Adverse Events Table F-4. … Cannabis RCTs adverse events Author, Year Companion Paper Risk of Bias Pain Population Category Specific … In addition, the number of reported adverse events in the nabilone/ GBP group decreased by 27% from Visits … events in the study. … Cannabis RCTs adverse events
  11. effectivehealthcare.ahrq.gov/products/diabetes-claims-data/research
    April 07, 2010 - For the clinical goal of assessing medication use in DMT2 patients, we focused on patients with adverse … DMT2 NC Medicaid patients, we identified 49 who had an MI, 173 who had a stroke, and 14 who had both events … extraction of clinically relevant text data regarding historical notations, negation, diagnostic issues, and adverse … With regard to the clinical goal of this project, patients who suffered adverse outcomes (MI, stroke, … These patients had relatively high utilization of care in the year before the adverse outcome, suggesting
  12. effectivehealthcare.ahrq.gov/products/erythropoiesis-stimulating-agents-utilization/research
    March 31, 2011 - to 12 grams per dL.5 A number of published studies, beginning in the late 1990s, suggested potential adverse … beneficiaries with kidney disease (KD) and to relate these trends to the timing of clinical practice and policy events
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-therapy-management_executive.pdf
    November 01, 2014 - adverse drug events, many patients do not receive optimal pharmaceutical prescriptions. … drug events. … drug events or mortality (Table D). … drug events, prescriber confusion, and prescriber dissatisfaction. … events.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
    April 01, 2013 - to adverse effects. … , intervention-group rates of events, or both. … • Health-related quality of life and serious adverse events were inconsistently reported in the seven … For adverse effects, we considered discontinuation due to adverse effects and worsening of psychiatric … , and adverse events Improved reporting of efficacy–effectiveness characteristics CATIE = Clinical
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
    September 13, 2013 - stratify the findings of the previous review, as well as any newly included studies on efficacy and adverse … or symptoms  Cerebrovascular events  Peripheral vascular events or symptoms  Cardiovascular death … strength Source: www.effectivehealthcare.ahrq.gov Published online: June 10, 2013 4 o Adverse … mortality  Cancer and cancer-specific mortality  Renal outcomes  Soft tissue calcification  (Other) adverse … For upper limit (adverse event [AE]) outcomes, we will include any adverse effects of high intake in
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
    October 01, 2016 - One RCT43 examined three possible harms: drug-related adverse effects; incidence of abnormal QT (QRS … flunitrazepam, no statistical testing reported (3 vs. 3, p=NR).48 Drug-related adverse events 91 … Few overall treatment-emergent adverse events with olanzapine vs. risperidone vs. haloperidol, p … =NR.72 Adverse events considered related to primary antipsychotic medication 558 Insufficient … No significant difference in discontinuation due to clinically significant adverse events with olanzapine
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
    February 01, 2012 - Mitigation of long-term adverse effects by changes in regimen, including reduced-intensity approaches … But, it is well recognized that regimens vary in their potential for long-term adverse effects. … Patients will need to be followed for at least 5 years for enough events to occur to enable a comparison … Patients will need to be followed for at least 5 years for enough events to occur to enable a comparison … Events This study is ongoing, but not recruiting participants.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
    November 01, 2012 - • No adverse events, except for a few cases of nausea, were reported in the trial evaluating bupropion … Risk of withdrawal due to adverse events appeared to differ between dopamine agonists (I2=73%, p=0.02 … events were reported. … events, and augmentation). … About half of withdrawals were due to adverse events, including augmentation; 20 percent to 30 percent
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_research-protocol.pdf
    October 18, 2010 - events associated with this therapy.† * Also see: Witter … While we agree there might be benefits to investigating serious and rare adverse events in an hypothesis … events Maternal side effects (pulmonary edema, heart failure, arrhythmia, myocardial infarction, … Further, data will be extracted as number of patients with an event (as opposed to number of events) … For rare outcomes, only studies with events recorded will be included in combined estimates.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
    May 01, 2013 - is the comparative effectiveness of aspirin and other antiplatelet agents in reducing the risk of adverse … What are the significant safety concerns associated with each treatment strategy (e.g., adverse drug … What are the significant safety concerns associated with each treatment strategy (e.g., adverse drug … What are the significant safety concerns associated with each treatment strategy (e.g., adverse drug … Some RCTs reported adverse events such as rash and wound leak.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: